ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 165 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $690,000 | -81.3% | 55,502 | -79.4% | 0.00% | -83.3% |
| Q3 2016 | $3,687,000 | +32.9% | 269,352 | -28.2% | 0.02% | +33.3% |
| Q2 2016 | $2,774,000 | +15.7% | 375,352 | 0.0% | 0.02% | +20.0% |
| Q1 2016 | $2,398,000 | +2.2% | 375,352 | 0.0% | 0.02% | +7.1% |
| Q4 2015 | $2,346,000 | +7.0% | 375,352 | 0.0% | 0.01% | +16.7% |
| Q3 2015 | $2,192,000 | -29.4% | 375,352 | 0.0% | 0.01% | -7.7% |
| Q2 2015 | $3,104,000 | +0.4% | 375,352 | 0.0% | 0.01% | +8.3% |
| Q1 2015 | $3,093,000 | +2.2% | 375,352 | -14.8% | 0.01% | +9.1% |
| Q4 2014 | $3,027,000 | +27.2% | 440,602 | 0.0% | 0.01% | +37.5% |
| Q3 2014 | $2,379,000 | -22.3% | 440,602 | -8.3% | 0.01% | -11.1% |
| Q2 2014 | $3,061,000 | -26.5% | 480,602 | -7.0% | 0.01% | -25.0% |
| Q1 2014 | $4,164,000 | -11.1% | 516,602 | -24.8% | 0.01% | -7.7% |
| Q4 2013 | $4,683,000 | – | 686,602 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |